This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

20 - 24 June 2022
Delivered as a Hybrid EventLive In-Person Event: 20-24 June 2022, Dublin, Ireland

20 - 24 June 2022
Delivered as a Hybrid Event,
Live In-Person Event: 20-24 June 2022, Dublin, Ireland

Is Your Biocompatibility Testing and Evaluations State Of The Art?

Combat your ISO 10993 hurdles and prove medical device safety with TC 194 Working Group, Competent Authority, Notified Body and industry guidance

Dive into data management, risk analysis, chemical characterization, TTC, ISO 10993-23, the EU MDR and more!

Optimise Your ISO 10993 Strategies With Expert Insights

Leading Biocompatibility Stakeholder Updates And Requirements

  • Understand Competent Authority expectations for biocompatibility testing with AFMPS
  • Get to grips with Notified Body requirements with TÜV SÜD
  • Get the latest ISO 10993-1, -10, -12 and -23 updates from TC 194 Working Group experts Beau Rollins and convenor Christian Pellevoisin

Learn From Fellow Medical Device Manufacturers Implementing ISO 10993

  • Navigate risk management with cases studies from Baxter and Bayer
  • Explore Chemical Characterisation with Zimmer Biomet
  • Put your questions to the panel on experiences with ISO 10993-17 & 18

Top Tips And Examples For Practical Application

  • Gain top tips for meeting reprocessed medical device requirements with CMR Surgical 
  • Benchmark experiences with the EU MDR and Biocompatibility with Karl Stoz
  • Get valuable insights into interpreting biocompatibility data with Merck

Mollie J. Holter

Consultant & Owner

MicroBio Consulting, LLC

“As a speaker new to the event, I found this a high quality conference with the right audience. The attendees were well educated asking good questions and demonstrated a good baseline knowledge of biocompatibility.”